|
RAPGEF6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28090000051095E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.31290001093021E-09 |
| Normal-vs-Stage2 |
2.801200E-03 |
| Normal-vs-Stage3 |
2.445500E-02 |
| Normal-vs-Stage4 |
3.485400E-01 |
| Stage1-vs-Stage2 |
7.336000E-01 |
| Stage1-vs-Stage3 |
9.522500E-03 |
| Stage1-vs-Stage4 |
8.770100E-04 |
| Stage2-vs-Stage3 |
1.434630E-01 |
| Stage2-vs-Stage4 |
2.735800E-02 |
| Stage3-vs-Stage4 |
3.209800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.31280000098744E-08 |
| Normal-vs-AfricanAmerican |
7.407000E-01 |
| Normal-vs-Asian |
1.232970E-01 |
| Caucasian-vs-AfricanAmerican |
9.362100E-03 |
| Caucasian-vs-Asian |
3.380000E-01 |
| AfricanAmerican-vs-Asian |
4.979800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.9129499999937E-05 |
| Normal-vs-Female |
7.98900000043012E-07 |
| Male-vs-Female |
2.032800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.695600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.84490000054716E-07 |
| Normal-vs-Age(61-80Yrs) |
5.51340000000122E-05 |
| Normal-vs-Age(81-100Yrs) |
1.845560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.966400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.694990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.840000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.100400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.053000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.603200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.209530E-02 |
| Normal-vs-Grade 2 |
1.82229997758299E-09 |
| Normal-vs-Grade 3 |
2.214000E-04 |
| Normal-vs-Grade 4 |
9.822200E-01 |
| Grade 1-vs-Grade 2 |
4.733600E-01 |
| Grade 1-vs-Grade 3 |
1.089960E-01 |
| Grade 1-vs-Grade 4 |
4.900000E-03 |
| Grade 2-vs-Grade 3 |
2.428000E-02 |
| Grade 2-vs-Grade 4 |
6.18689999999367E-05 |
| Grade 3-vs-Grade 4 |
1.048270E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.67403893367191E-14 |
| Normal-vs-ccB subtype |
2.608300E-02 |
| ccA subtype-vs-ccB subtype |
1.70600000015675E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.45409999999335E-06 |
| Normal-vs-N1 |
5.509400E-01 |
| N0-vs-N1 |
3.647000E-01 |
|
|
